The MedicX Fund Limited Allotment of scrip shares to Directors (5637L)
04 October 2016 - 3:35AM
UK Regulatory
TIDMMXF
RNS Number : 5637L
The MedicX Fund Limited
03 October 2016
Press Release
For immediate release
3 October 2016
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Allotment of scrip shares to Directors of the Company
Members of the Company's Board of Directors elected to
participate in the Company's scrip dividend scheme in respect of
the September 2016 dividend for the quarter ended 30 June 2016, and
accordingly acquired ordinary shares of no par value in the Company
(the "Shares") as disclosed in the table below. The Shares were
sold out of treasury by the Company at the previously advised scrip
calculation price of 90.55 pence per share.
Shares Total Percentage
Acquired Shares Holding
Held
David Staples
(Chairman) 1,481 91,683 0.024%
Shelagh Mason 495 30,681 0.008%
John Hearle 483 29,942 0.008%
The Shares were acquired on 30 September 2016 and rank pari
passu with the Company's existing ordinary shares.
The Directors detailed above, who elected to participate in the
Company's scrip dividend scheme, did so under an election mandate
which remains in place until revoked.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the
Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom,
listed on the London Stock Exchange, with a portfolio comprising
152 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on four core areas: GP surgeries, care
homes, retirement housing and private hospitals. Octopus Healthcare
is part of the Octopus group, a fast-growing UK fund management
business with leading positions in several specialist sectors
including healthcare property, energy, property finance and smaller
company investing. Octopus manages GBP5.5 billion of funds for more
than 50,000 retail and institutional investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEZMMGGVFLGVZM
(END) Dow Jones Newswires
October 03, 2016 12:35 ET (16:35 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024